Silver Book Fact

A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.

Bradley, C, K Yabroff, B Dahman, E Feuer, A Mariotto, et al. Productivity Costs of Cancer Mortality in the United States: 2000-2020. J Natl Cancer Inst. 2008; 100(24): 1763-70. http://www.ncbi.nlm.nih.gov/pubmed/19066273

Reference

Title
Productivity Costs of Cancer Mortality in the United States: 2000-2020
Publication
J Natl Cancer Inst
Publication Date
2008
Authors
Bradley, C, K Yabroff, B Dahman, E Feuer, A Mariotto, et al.
Volume & Issue
Volume 100, Issue 24
Pages
1763-70
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Use of a monocolonal antibody with adjuvant chemotherapy in HER2+ individuals with operable cancer was associated with a 33 percent reduction in risk of death.  
  • Every additional dollar spent on newer, less toxic hormonal therapy for breast cancer patients has produced health gains valued at between $27.03 and $36.81.  
  • Following the current path, the colon cancer incidence rate will increase by 31.8% between 2003 and 2023 (447,000 people). If an alternative path is taken, there will be 17.7% (79,000…  
  • Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicines in development.  
  • In the U.S., new cancer drugs have increased life expectancy at birth by 10.7%.